Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Grifols, S.A. (NASDAQ: GRFS) Short Seller Report: Kaplan Fox Investigates Grifols, S.A. By: TheNewswire.com April 02, 2024 at 11:55 AM EDT NEW YORK, NY - (NewMediaWire) - April 2, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Grifols, S.A. (NASDAQ: GRFS) securities. Click Here to Join the Investigation.If you purchased Grifols securities and would like to discuss this notice, your rights, or your interests please click here. You may also contact us by emailing jcampisi@kaplanfox.com or calling (212) 329-8571.On March 22, 2024, Bloomberg published a story titled “Grifols Drops as Regulator Finds ‘Relevant Deficiencies’” that stated, in part, that “The regulator opened its review of Grifols’ earnings in January after the company was targeted by short-seller Gotham City Research, which accused Grifols of deceptive accounting and poor governance. While Grifols has denied the allegations, its shares have suffered . . . The regulator has given Grifols 15 days to publish ‘commitments to adequate its alternative performance metrics in upcoming financial reports’ as well as additional data on Ebitda and net financial debt for relevant companies in which it has non-controlling stakes. The regulator said that the conclusions of its review could potentially lead to sanctions for Grifols, though that decision may take several months.”On March 22, 2024, Grifols securities traded on Nasdaq declined $0.56 per share or approximately 8.3%.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in complex litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this notice, your rights, or your interests, please contact:Jeffrey P. Campisi, Esq.KAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(212) 329-8571E-mail: jcampisi@kaplanfox.com Laurence D. King, Esq.KAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Grifols, S.A. (NASDAQ: GRFS) Short Seller Report: Kaplan Fox Investigates Grifols, S.A. By: TheNewswire.com April 02, 2024 at 11:55 AM EDT NEW YORK, NY - (NewMediaWire) - April 2, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Grifols, S.A. (NASDAQ: GRFS) securities. Click Here to Join the Investigation.If you purchased Grifols securities and would like to discuss this notice, your rights, or your interests please click here. You may also contact us by emailing jcampisi@kaplanfox.com or calling (212) 329-8571.On March 22, 2024, Bloomberg published a story titled “Grifols Drops as Regulator Finds ‘Relevant Deficiencies’” that stated, in part, that “The regulator opened its review of Grifols’ earnings in January after the company was targeted by short-seller Gotham City Research, which accused Grifols of deceptive accounting and poor governance. While Grifols has denied the allegations, its shares have suffered . . . The regulator has given Grifols 15 days to publish ‘commitments to adequate its alternative performance metrics in upcoming financial reports’ as well as additional data on Ebitda and net financial debt for relevant companies in which it has non-controlling stakes. The regulator said that the conclusions of its review could potentially lead to sanctions for Grifols, though that decision may take several months.”On March 22, 2024, Grifols securities traded on Nasdaq declined $0.56 per share or approximately 8.3%.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in complex litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this notice, your rights, or your interests, please contact:Jeffrey P. Campisi, Esq.KAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(212) 329-8571E-mail: jcampisi@kaplanfox.com Laurence D. King, Esq.KAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com
NEW YORK, NY - (NewMediaWire) - April 2, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Grifols, S.A. (NASDAQ: GRFS) securities. Click Here to Join the Investigation.If you purchased Grifols securities and would like to discuss this notice, your rights, or your interests please click here. You may also contact us by emailing jcampisi@kaplanfox.com or calling (212) 329-8571.On March 22, 2024, Bloomberg published a story titled “Grifols Drops as Regulator Finds ‘Relevant Deficiencies’” that stated, in part, that “The regulator opened its review of Grifols’ earnings in January after the company was targeted by short-seller Gotham City Research, which accused Grifols of deceptive accounting and poor governance. While Grifols has denied the allegations, its shares have suffered . . . The regulator has given Grifols 15 days to publish ‘commitments to adequate its alternative performance metrics in upcoming financial reports’ as well as additional data on Ebitda and net financial debt for relevant companies in which it has non-controlling stakes. The regulator said that the conclusions of its review could potentially lead to sanctions for Grifols, though that decision may take several months.”On March 22, 2024, Grifols securities traded on Nasdaq declined $0.56 per share or approximately 8.3%.WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in complex litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.If you have any questions about this notice, your rights, or your interests, please contact:Jeffrey P. Campisi, Esq.KAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(212) 329-8571E-mail: jcampisi@kaplanfox.com Laurence D. King, Esq.KAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704Fax: (415) 772-4707E-mail: lking@kaplanfox.com